Machinemedicine

Machine Medicine operates at the intersection of digital health, clinical research, computer vision, and neurological assessment. Its stated ambition is broader than a single Parkinson’s assessment app: the company describes an operating system for neuromodulation and precision neurotherapeutics, while its Kelvin tools address patient assessment, clinical data handling, and analysis. The described workflow spans remote and in-clinic assessments, multimodal data integration, study management, and AI analysis, with computer-vision functions such as pose estimation and activity recognition. The available peer list identifies Machine Medicine itself rather than independent comparable companies, so specific competitors cannot be reliably named from the information available. Its position is best characterized as a specialist software platform for clinical and research teams working with neurological and other disease-related data, rather than as a confirmed market leader.

Machine Medicine was founded on May 24, 2017 and has a seven-round financing history, with recorded activity spanning a convertible note in 2018, seed rounds in 2019, 2020, and 2022, non-equity assistance in 2023, and further financing activity in 2024. Product descriptions indicate an expansion from video-based Parkinson’s motor assessment toward a broader Kelvin suite for remote and clinic workflows, data integration, cloud management, and analysis. That suggests an evolution in product scope, not proof of customer or revenue growth. The employee range is listed as 11–50, while the record also lists one current position; those measures do not align cleanly and should not be read as evidence of hiring or contraction.